HEADER OXIDOREDUCTASE 14-MAR-05 1Z3N TITLE HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR TITLE 2 LIDORESTAT AT 1.04 ANGSTROM COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.1.1.21; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS OXIDOREDUCTASE, NADP+, LIDORESTAT EXPDTA X-RAY DIFFRACTION AUTHOR M.C.VAN ZANDT,M.L.JONES,D.E.GUNN,L.S.GERACI,J.H.JONES,D.R.SAWICKI, AUTHOR 2 J.SREDY,J.L.JACOT,A.T.DICIOCCIO,T.PETROVA,A.MITSCHLER,A.D.PODJARNY REVDAT 3 13-MAR-24 1Z3N 1 REMARK SEQADV REVDAT 2 24-FEB-09 1Z3N 1 VERSN REVDAT 1 14-MAR-06 1Z3N 0 JRNL AUTH M.C.VAN ZANDT,M.L.JONES,D.E.GUNN,L.S.GERACI,J.H.JONES, JRNL AUTH 2 D.R.SAWICKI,J.SREDY,J.L.JACOT,A.T.DICIOCCIO,T.PETROVA, JRNL AUTH 3 A.MITSCHLER,A.D.PODJARNY JRNL TITL DISCOVERY OF JRNL TITL 2 3-[(4,5,7-TRIFLUOROBENZOTHIAZOL-2-YL)METHYL]INDOLE-N-ACETIC JRNL TITL 3 ACID (LIDORESTAT) AND CONGENERS AS HIGHLY POTENT AND JRNL TITL 4 SELECTIVE INHIBITORS OF ALDOSE REDUCTASE FOR TREATMENT OF JRNL TITL 5 CHRONIC DIABETIC COMPLICATIONS JRNL REF J.MED.CHEM. V. 48 3141 2005 JRNL REFN ISSN 0022-2623 JRNL PMID 15857120 JRNL DOI 10.1021/JM0492094 REMARK 2 REMARK 2 RESOLUTION. 1.04 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.04 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.3 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.098 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.097 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.125 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 6975 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 132616 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.090 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.118 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 6201 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 117067 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2525 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 397 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2963.8 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 107 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 31049 REMARK 3 NUMBER OF RESTRAINTS : 43650 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.017 REMARK 3 ANGLE DISTANCES (A) : 0.032 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.112 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.105 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.031 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.006 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.050 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.122 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Z3N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-MAR-05. REMARK 100 THE DEPOSITION ID IS D_1000032256. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-SEP-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : LURE REMARK 200 BEAMLINE : DW32 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 139636 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.040 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.2 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04000 REMARK 200 FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.25200 REMARK 200 FOR SHELL : 4.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ALDOSE REDUCTASE, LIDORESTAT, NADP+, REMARK 280 PEG 6000, PH 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.67000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 0 CG - SD - CE ANGL. DEV. = 13.0 DEGREES REMARK 500 ARG A 3 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 3 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES REMARK 500 ARG A 3 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG A 40 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 63 CG - CD - NE ANGL. DEV. = 13.9 DEGREES REMARK 500 ARG A 63 CD - NE - CZ ANGL. DEV. = 8.6 DEGREES REMARK 500 ARG A 63 CD - NE - CZ ANGL. DEV. = 13.1 DEGREES REMARK 500 ARG A 63 NE - CZ - NH2 ANGL. DEV. = -4.5 DEGREES REMARK 500 ASP A 149 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 TYR A 198 CB - CG - CD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 217 NE - CZ - NH2 ANGL. DEV. = 4.5 DEGREES REMARK 500 CYS A 298 CA - CB - SG ANGL. DEV. = -11.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 65 32.16 73.30 REMARK 500 ALA A 299 109.29 -164.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ARG A 40 -12.78 REMARK 500 ARG A 40 15.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 318 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3NA A 320 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1US0 RELATED DB: PDB DBREF 1Z3N A 0 315 GB 178489 AAA51714 1 316 SEQADV 1Z3N GLY A -3 GB 178489 EXPRESSION TAG SEQADV 1Z3N SER A -2 GB 178489 EXPRESSION TAG SEQADV 1Z3N HIS A -1 GB 178489 EXPRESSION TAG SEQRES 1 A 319 GLY SER HIS MET ALA SER ARG ILE LEU LEU ASN ASN GLY SEQRES 2 A 319 ALA LYS MET PRO ILE LEU GLY LEU GLY THR TRP LYS SER SEQRES 3 A 319 PRO PRO GLY GLN VAL THR GLU ALA VAL LYS VAL ALA ILE SEQRES 4 A 319 ASP VAL GLY TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR SEQRES 5 A 319 GLN ASN GLU ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS SEQRES 6 A 319 LEU ARG GLU GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE SEQRES 7 A 319 VAL SER LYS LEU TRP CYS THR TYR HIS GLU LYS GLY LEU SEQRES 8 A 319 VAL LYS GLY ALA CYS GLN LYS THR LEU SER ASP LEU LYS SEQRES 9 A 319 LEU ASP TYR LEU ASP LEU TYR LEU ILE HIS TRP PRO THR SEQRES 10 A 319 GLY PHE LYS PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SEQRES 11 A 319 SER GLY ASN VAL VAL PRO SER ASP THR ASN ILE LEU ASP SEQRES 12 A 319 THR TRP ALA ALA MET GLU GLU LEU VAL ASP GLU GLY LEU SEQRES 13 A 319 VAL LYS ALA ILE GLY ILE SER ASN PHE ASN HIS LEU GLN SEQRES 14 A 319 VAL GLU MET ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS SEQRES 15 A 319 PRO ALA VAL ASN GLN ILE GLU CYS HIS PRO TYR LEU THR SEQRES 16 A 319 GLN GLU LYS LEU ILE GLN TYR CYS GLN SER LYS GLY ILE SEQRES 17 A 319 VAL VAL THR ALA TYR SER PRO LEU GLY SER PRO ASP ARG SEQRES 18 A 319 PRO TRP ALA LYS PRO GLU ASP PRO SER LEU LEU GLU ASP SEQRES 19 A 319 PRO ARG ILE LYS ALA ILE ALA ALA LYS HIS ASN LYS THR SEQRES 20 A 319 THR ALA GLN VAL LEU ILE ARG PHE PRO MET GLN ARG ASN SEQRES 21 A 319 LEU VAL VAL ILE PRO LYS SER VAL THR PRO GLU ARG ILE SEQRES 22 A 319 ALA GLU ASN PHE LYS VAL PHE ASP PHE GLU LEU SER SER SEQRES 23 A 319 GLN ASP MET THR THR LEU LEU SER TYR ASN ARG ASN TRP SEQRES 24 A 319 ARG VAL CYS ALA LEU LEU SER CYS THR SER HIS LYS ASP SEQRES 25 A 319 TYR PRO PHE HIS GLU GLU PHE HET NDP A 318 48 HET 3NA A 320 26 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM 3NA {3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H- HETNAM 2 3NA INDOL-1-YL}ACETIC ACID HETSYN 3NA 3-[(4,5,7-TRIFLUOROBENZOTHIAZOL-2-YL)METHYL]INDOLE-N- HETSYN 2 3NA ACETIC ACID FORMUL 2 NDP C21 H30 N7 O17 P3 FORMUL 3 3NA C18 H11 F3 N2 O2 S FORMUL 4 HOH *397(H2 O) HELIX 1 1 PRO A 23 GLY A 38 1 16 HELIX 2 2 ALA A 45 GLN A 49 5 5 HELIX 3 3 ASN A 50 GLU A 64 1 15 HELIX 4 4 LYS A 68 LEU A 72 5 5 HELIX 5 5 TRP A 79 HIS A 83 5 5 HELIX 6 6 GLU A 84 GLY A 86 5 3 HELIX 7 7 LEU A 87 LYS A 100 1 14 HELIX 8 8 ASN A 136 GLU A 150 1 15 HELIX 9 9 ASN A 162 ASN A 171 1 10 HELIX 10 10 GLN A 192 LYS A 202 1 11 HELIX 11 11 SER A 226 GLU A 229 5 4 HELIX 12 12 ASP A 230 ASN A 241 1 12 HELIX 13 13 THR A 243 GLN A 254 1 12 HELIX 14 14 THR A 265 LYS A 274 1 10 HELIX 15 15 SER A 281 SER A 290 1 10 HELIX 16 16 LEU A 300 THR A 304 5 5 SHEET 1 A 2 ARG A 3 LEU A 5 0 SHEET 2 A 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 B 8 GLY A 16 GLY A 18 0 SHEET 2 B 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17 SHEET 3 B 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 B 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 B 8 ILE A 156 SER A 159 1 O GLY A 157 N ILE A 109 SHEET 6 B 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 B 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184 SHEET 8 B 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 36 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC1 36 ASP A 43 TYR A 48 HIS A 110 TRP A 111 SITE 3 AC1 36 SER A 159 ASN A 160 GLN A 183 TYR A 209 SITE 4 AC1 36 SER A 210 PRO A 211 LEU A 212 GLY A 213 SITE 5 AC1 36 SER A 214 PRO A 215 ASP A 216 ALA A 245 SITE 6 AC1 36 ILE A 260 PRO A 261 LYS A 262 SER A 263 SITE 7 AC1 36 VAL A 264 THR A 265 ARG A 268 GLU A 271 SITE 8 AC1 36 ASN A 272 3NA A 320 HOH A2085 HOH A2147 SITE 9 AC1 36 HOH A2149 HOH A2167 HOH A2168 HOH A2169 SITE 1 AC2 16 TRP A 20 TYR A 48 TRP A 79 CYS A 80 SITE 2 AC2 16 HIS A 110 TRP A 111 THR A 113 PHE A 115 SITE 3 AC2 16 PHE A 122 TRP A 219 CYS A 298 ALA A 299 SITE 4 AC2 16 LEU A 300 CYS A 303 TYR A 309 NDP A 318 CRYST1 50.140 67.340 47.880 90.00 92.50 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019944 0.000000 0.000871 0.00000 SCALE2 0.000000 0.014850 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020905 0.00000